Sexuality News

Almost 90% of women veterans involved with the criminal justice system have been diagnosed with a mental health disorder, and more than half with a substance use disorder, according to data published in Medical Care.

Sex-specific mental health needs are evident among women veterans seeking psychiatric care in VA clinics, according to data published in Medical Care.

More than 20% of female students and 10% of male students experience some form of teen dating violence, according to findings from the 2013 National Youth Risk Behavior Survey.

Adolescents who disclosed that they were gay, lesbian, bisexual or transgender to their peers at school had greater self-esteem and less symptoms of depression during young adulthood, according to data published in the American Journal of Orthopsychiatry.

Sprout Pharmaceuticals has resubmitted a new drug application to the FDA for flibanserin, an investigational therapy to treat hypoactive sexual desire disorder in women during premenopause, according to a news release from the company.

Vaginal dryness and dyspareunia are common in women with Sjögren’s syndrome, and patients may be hesitant to discuss their concerns with a physician, according to researchers from the University of Groningen in the Netherlands.

Transgender youth had a two to threefold increased risk for depression, anxiety disorder, suicidal ideation, suicide attempt, self-harm without lethal intent, and both inpatient and outpatient mental health treatment, according to data published in the Journal of Adolescent Health.

Homosexual, bisexual and heterosexual men and women react differently to feelings of jealousy over sexual and emotional infidelity, according to researchers.

Prevention programs within the community, at school and through parenting may be efficacious in deterring adolescent intimate partner violence and sexual violence, according to researchers.

Among individuals with gender dysphoria who initiated gender reassignment during adolescence, gonadotropin-releasing hormone analogue therapy may delay or diminish achievement of peak bone mass potential, according to recent findings.